Cite

HARVARD Citation

    Chaudhary, M. et al. (2021). Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data. Journal of medical economics. pp. 607-619. [Online]. 
  
Back to record